American Oncology Network, Inc.

Total Valuation

American Oncology Network, Inc. carries a market capitalization of 292.48M, placing it among publicly traded companies globally. Its enterprise value stands at 283.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

American Oncology Network, Inc. currently has 27.23M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 0.03, and the price-to-book ratio stands at -0.53.

Enterprise Valuation

On an enterprise value basis, American Oncology Network, Inc. trades at an EV/EBITDA multiple of 86.34 and an EV/FCF ratio of 11.91.

Financial Position

American Oncology Network, Inc. maintains a current ratio of 1.53, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 136.44, indicating elevated leverage, while an interest coverage ratio of 0.46 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

American Oncology Network, Inc.'s stock has declined approximately -9.09091% over the past 52 weeks. The 50-day moving average sits at 11.20, while the 200-day moving average is 10.26.

Income Statement

Over the trailing twelve months, American Oncology Network, Inc. generated 1.76B in revenue and converted that into -3.97M in net income, yielding earnings per share of -1.40. EBITDA reached 3.28M, while operating income came in at -16.09M.

Balance Sheet

American Oncology Network, Inc. holds 72.64M in cash and equivalents against 147.37M in total debt, resulting in a net debt position of 28.02M. Total book value stands at -102.17M, with working capital of 114.63M providing operational flexibility.

Cash Flow

American Oncology Network, Inc. produced -4.94M in operating cash flow over the past twelve months. After subtracting -20.95M in capital expenditures, free cash flow totaled -25.90M - equivalent to -2.42 per share.

Margins

American Oncology Network, Inc. operates with a gross margin of 6.70, reflecting its pricing power and cost economics. The operating margin of -0.91 and net profit margin of -0.23 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 10.00 indicates the proportion of earnings distributed to shareholders.

Scores

American Oncology Network, Inc. posts an Altman Z-Score of 3.81, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.